Former Jamieson Labs head Vic Neufeld named CEO of newly funded Aphria
Vic Neufeld, former president and CEO of vitamins, minerals and nutrition supplements wholesaler Jamieson Laboratories Ltd, has become the CEO and founding investor in Aphria Inc, a natural alternative health care provider and portfolio company of Canadian private equity firm Delavaco Group. Jamieson was acquired last January by CCMP Capital Advisors, a U.S. private equity firm. Founded in 2013 and based in Leamington, Ontario, Aphria is focused on the low-cost growth and distribution of medical marijuana. Delavaco also announced that it has completed an equity investment and $6.2 million private placement funding for the company.



